Structure-activity relationships of some taxoids as multidrug resistance modulator

被引:7
|
作者
Hasegawa, Toshiaki
Bai, Jao
Zhang, Shujun
Wang, Jinlan
Matsubara, Junichi
Kawakami, Junichi
Tomida, Akihiro
Tsuruo, Takashi
Hirose, Katsutoshi
Sakai, Junichi
Kikuchi, Midori
Abe, Mariko
Ando, Masayoshi
机构
[1] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan
[2] Niigata Univ, Dept Chem & Chem Engn, Fac Engn, Niigata 9502181, Japan
[3] Mitsubishi Gas Chem Co Inc, Niigata Res Lab, Niigata 9503112, Japan
[4] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan
[5] Kobe Nat Prod & Chem Co Ltd, Kanzaki, Hyogo 6792315, Japan
关键词
taxoid; taxinine; 1,7-deoxy-4-deacetylbaccatin III; MDR; cytotoxicity;
D O I
10.1016/j.bmcl.2006.09.068
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1,7-Deoxy-4-deacetylbaccatin III (12) and its five analogues 6-9, 13, and their oxetane ring opened derivatives 14, 16, and 17, which were synthesized from taxinine, showed significant activity as MDR reversal agent by the assay of the calcein accumulation toward MDR human ovarian cancer 2780AD cells. The most effective compound 12 in this assay is actually efficient for the recovery of cytotoxic activity of paclitaxel (taxol), adriamycin (ADM), and vincristine (VCR) toward MDR 2780AD cells at the same level toward parental 2780 cells. This activity of 12 is very interesting because baccatin 111 (4) has no such MDR reversal activity but has cytotoxic activity. The essential functional groups inducing such a difference in biological activity between 4 and 12 are 4 alpha-acetoxyl for 4 and 4 alpha-hydroxyl for 12. In seven compounds possessing MDR reversal activity, compound 12 is the most desirable compound for anti-MDR cancer reversal agent, because it has the highest accumulation ability of anticancer agent in MDR cancer cells and weak cytotoxic activity. Compounds 8 and 13 showed significant cytotoxic activity toward HepG2 and VA-13, respectively, as well as MDR reversal activity. They are expected to become lead compounds for new types of anticancer agent or anti-MDR cancer agent. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1122 / 1126
页数:5
相关论文
共 50 条
  • [1] Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells
    Hasegawa, Toshiaki
    Bai, Jiao
    Dai, Jungui
    Bai, Liming
    Sakai, Junichi
    Nishizawa, Shigenori
    Bai, Yuhua
    Kikuchi, Midorl
    Abe, Mariko
    Yamori, Takao
    Tomida, Akihiro
    Tsuruo, Takashi
    Hirose, Katsutoshi
    Ando, Masayoshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) : 3722 - 3728
  • [2] Synthesis and structure-activity relationships of sinenxan A derivatives as multidrug resistance reversal agents
    Huang, Meng
    Zhao, Xin
    Zhang, Meng
    Gu, Jun
    Chen, Xiaoguang
    Yin, Dali
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (18) : 5418 - 5421
  • [3] P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS
    Huber, Paula C.
    Maruiama, Cintia H.
    Almeida, Wanda P.
    QUIMICA NOVA, 2010, 33 (10): : 2148 - 2154
  • [4] Syntheses and structure-activity relationships of novel 3′-difluoromethyl and 3′-trifluoromethyl-taxoids
    Kuznetsova, Larissa V.
    Pepe, Antonella
    Ungureanu, Loana M.
    Pera, Paula
    Bernacki, Ralph J.
    Ojima, Iwao
    JOURNAL OF FLUORINE CHEMISTRY, 2008, 129 (09) : 817 - 828
  • [5] Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship
    Qing, Zhi-Xing
    Huang, Jia-Lu
    Yang, Xue-Yi
    Liu, Jing-Hong
    Cao, Hua-Liang
    Xiang, Feng
    Cheng, Pi
    Zeng, Jian-Guo
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (38) : 5088 - 5114
  • [6] Structure-activity relationships of some hederagenin diglycosides:: Haemolysis, cytotoxicity and apoptosis induction
    Chwalek, Martin
    Lalun, Nathalie
    Bobichon, Helene
    Ple, Karen
    Voutquenne-Nazabadioko, Laurence
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (09): : 1418 - 1427
  • [7] Structure-activity relationships of synthetic cardiac glycosides
    Takechi, M
    Uno, C
    Tanaka, Y
    PHYTOCHEMISTRY, 1996, 41 (01) : 125 - 127
  • [8] Bis-pyrazolylpyridine complexes of some transition metal ions: Structure-Activity Relationships and Biological Activity
    Simovic, Ana Rilak
    Bogojeski, Jovana
    Petrovic, Biljana
    Jovanovic-Stevic, Snezana
    MACROHETEROCYCLES, 2020, 13 (03): : 201 - 209
  • [9] Brassinosteroids and analogs as neuroprotectors: Synthesis and structure-activity relationships
    Ismaili, Jihane
    Boisvert, Martin
    Longpre, Fanny
    Carange, Julie
    Le Gall, Celine
    Martinoli, Maria-Grazia
    Daoust, Benoit
    STEROIDS, 2012, 77 (1-2) : 91 - 99
  • [10] Preparation and structure-activity relationships of novel asterriquinone derivatives
    Kaji, A
    Kimura, K
    Teranishi, M
    Kiriyama, N
    Nomura, M
    Miyamoto, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1998, 46 (08) : 1325 - 1329